STERIS Q4 Earnings Call Highlights

STERIS NYSE: STE reported a stronger fiscal 2026 overall despite a lighter fourth quarter, with executives pointing to record annual revenue, resilient procedure demand and continued pricing gains, while also outlining expectations for mid- to high-single-digit growth in fiscal 2027.

MarketBeat • May 15, 2026

STERIS plc (STE) Q4 2026 Earnings Call Transcript

STERIS plc (STE) Q4 2026 Earnings Call Transcript

Seeking Alpha • May 12, 2026

STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading

STERIS posts Q4 adjusted EPS of $2.83 and revenues of $1.59 billion, both slight misses; shares dip after hours despite broad growth and FY27 guidance.

Zacks Investment Research • May 12, 2026

Steris forecasts 2027 profit above estimates, banks on procedure-driven demand

Medical equipment maker Steris forecast fiscal 2027 profit above Wall Street expectations ​on Monday, betting on strong demand ‌for its sterilization services despite narrowly missing estimates for fourth-quarter adjusted profit.

Reuters • May 11, 2026

STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year

DUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026. Total revenue from continuing operations for the fourth quarter of fiscal 2026 increased 7% to $1.6 billion compared with $1.5 billion in the fourth quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations grew 5% in the fourth quarter.

GlobeNewsWire • May 11, 2026

Steris (STE) Q4 Earnings and Revenues Miss Estimates

Steris (STE) came out with quarterly earnings of $2.83 per share, missing the Zacks Consensus Estimate of $2.86 per share. This compares to earnings of $2.74 per share a year ago.

Zacks Investment Research • May 11, 2026

STERIS Appoints Pierre Boulud to Board of Directors

DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board of Directors. “We are pleased to welcome Pierre to our Board,” said Mohsen Sohi, Chairman of STERIS.

GlobeNewsWire • May 7, 2026

STERIS Announces Dividend of $0.63 per share

DUBLIN, IRELAND, May 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on June 26, 2026, to shareholders of record at the close of business on June 8, 2026.

GlobeNewsWire • May 5, 2026

STERIS' Q4 Earnings on Deck: What's in Store for the Stock?

STERIS plc STE is scheduled to release fourth-quarter fiscal 2026 results on May 12, after market close.

Zacks Investment Research • May 4, 2026

STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026

DUBLIN, IRELAND, April 21, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 fourth quarter and full year results at 9:00 a.m. ET on May 12, 2026.

GlobeNewsWire • Apr 21, 2026